NK Cell Memory to Cytomegalovirus: Implications for Vaccine Development.

HCMV MCMV NK cytomegalovirus memory natural killer

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
20 Jul 2020
Historique:
received: 24 06 2020
revised: 13 07 2020
accepted: 15 07 2020
entrez: 24 7 2020
pubmed: 24 7 2020
medline: 24 7 2020
Statut: epublish

Résumé

Natural killer (NK) cells are innate lymphoid cells that recognize and eliminate virally-infected and cancerous cells. Members of the innate immune system are not usually considered to mediate immune memory, but over the past decade evidence has emerged that NK cells can do this in several contexts. Of these, the best understood and most widely accepted is the response to cytomegaloviruses, with strong evidence for memory to murine cytomegalovirus (MCMV) and several lines of evidence suggesting that the same is likely to be true of human cytomegalovirus (HCMV). The importance of NK cells in the context of HCMV infection is underscored by the armory of NK immune evasion genes encoded by HCMV aimed at subverting the NK cell immune response. As such, ongoing studies that have utilized HCMV to investigate NK cell diversity and function have proven instructive. Here, we discuss our current understanding of NK cell memory to viral infection with a focus on the response to cytomegaloviruses. We will then discuss the implications that this will have for the development of a vaccine against HCMV with particular emphasis on how a strategy that can harness the innate immune system and NK cells could be crucial for the development of a vaccine against this high-priority pathogen.

Identifiants

pubmed: 32698362
pii: vaccines8030394
doi: 10.3390/vaccines8030394
pmc: PMC7563466
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Wellcome Trust
ID : 204870/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT105677
Pays : United Kingdom
Organisme : Rosetrees Trust
ID : A2207
Organisme : Rosetrees Trust
ID : A1601

Références

Immunity. 2001 Feb;14(2):123-33
pubmed: 11239445
PLoS Comput Biol. 2016 Mar 21;12(3):e1004801
pubmed: 26998760
Cell Host Microbe. 2014 Aug 13;16(2):201-214
pubmed: 25121749
Nat Immunol. 2008 May;9(5):495-502
pubmed: 18425106
J Clin Invest. 2013 Apr;123(4):1444-56
pubmed: 23524967
J Exp Med. 2012 May 7;209(5):947-54
pubmed: 22493516
Vaccine. 2018 Mar 14;36(12):1689-1699
pubmed: 29456015
J Immunol. 2019 Sep 15;203(6):1609-1618
pubmed: 31427444
Immunol Rev. 2019 Jan;287(1):202-225
pubmed: 30565241
J Virol. 2018 Aug 16;92(17):
pubmed: 29950412
Cell Rep. 2016 May 3;15(5):1088-1099
pubmed: 27117418
Lancet. 1974 Jan 5;1(7845):1-5
pubmed: 4128996
Cell. 2017 Mar 23;169(1):58-71.e14
pubmed: 28340350
Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):11579-11584
pubmed: 30249666
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):6104-6109
pubmed: 28533400
Cell Host Microbe. 2013 Mar 13;13(3):324-35
pubmed: 23498957
J Infect Dis. 2019 Dec 10;:
pubmed: 31821493
J Immunol. 2010 Sep 1;185(5):2808-18
pubmed: 20679529
Cell Rep. 2015 Feb 17;10(6):968-982
pubmed: 25683719
Adv Immunol. 2017;133:171-207
pubmed: 28215279
Nat Immunol. 2008 May;9(5):477-80
pubmed: 18425103
Clinics (Sao Paulo). 2015 Jul;70(7):515-23
pubmed: 26222822
J Gen Virol. 2010 Aug;91(Pt 8):2034-2039
pubmed: 20410314
J Infect Dis. 1999 Oct;180(4):970-5
pubmed: 10479120
Clin Infect Dis. 2004 Jul 15;39(2):233-9
pubmed: 15307033
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7570-5
pubmed: 12032324
J Exp Med. 2012 Dec 17;209(13):2351-65
pubmed: 23209317
Nat Immunol. 2001 Oct;2(10):951-6
pubmed: 11550009
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1915-9
pubmed: 19181844
PLoS Pathog. 2017 Jun 19;13(6):e1006454
pubmed: 28628650
Cell Mol Immunol. 2010 Sep;7(5):381-8
pubmed: 20543857
Vaccine. 2016 Jan 12;34(3):313-9
pubmed: 26657184
Blood. 2006 Jan 1;107(1):159-66
pubmed: 16150947
Nat Immunol. 2006 May;7(5):507-16
pubmed: 16617337
J Virol. 1995 Aug;69(8):4830-41
pubmed: 7609050
Cell. 2017 Nov 2;171(4):795-808.e12
pubmed: 29056343
NPJ Vaccines. 2020 Apr 14;5:32
pubmed: 32337075
N Engl J Med. 1989 Jun 29;320(26):1731-5
pubmed: 2543925
Nat Immunol. 2010 Dec;11(12):1127-35
pubmed: 20972432
Blood. 2004 Dec 1;104(12):3664-71
pubmed: 15304389
Hematol Oncol Clin North Am. 2011 Feb;25(1):151-69
pubmed: 21236396
J Immunol. 2003 Jul 15;171(2):902-8
pubmed: 12847260
J Pathol. 2015 Jan;235(2):288-97
pubmed: 25205255
Vaccine. 2014 May 13;32(23):2756-62
pubmed: 23867012
Nature. 1996 Dec 5;384(6608):432-8
pubmed: 8945469
Oncoimmunology. 2016 Aug 5;5(9):e1219009
pubmed: 27757318
PLoS One. 2014 Jan 14;9(1):e85587
pubmed: 24454895
Clin Infect Dis. 2006 Nov 1;43(9):1143-51
pubmed: 17029132
Blood Adv. 2020 Apr 14;4(7):1388-1406
pubmed: 32271902
J Clin Invest. 2014 Dec;124(12):5305-16
pubmed: 25384219
J Infect Dis. 2018 May 25;217(12):1907-1917
pubmed: 29528415
Nat Immunol. 2015 Sep;16(9):927-32
pubmed: 26193080
J Virol. 2009 Apr;83(8):3891-903
pubmed: 19193805
J Exp Med. 2005 Jun 20;201(12):1999-2010
pubmed: 15967826
Immunol Rev. 2000 Apr;174:5-20
pubmed: 10807503
Front Immunol. 2019 Aug 02;10:1679
pubmed: 31428084
Blood. 2008 Aug 1;112(3):914-5
pubmed: 18650467
Rev Med Virol. 2011 Jan;21(1):54-61
pubmed: 21246642
PLoS Pathog. 2014 May 15;10(5):e1004131
pubmed: 24830376
Vaccine. 2017 Jul 24;35(33):4064-4071
pubmed: 28647170
PLoS One. 2015 Mar 17;10(3):e0121258
pubmed: 25781472
Nat Immunol. 2005 May;6(5):515-23
pubmed: 15821739
PLoS One. 2013;8(3):e59863
pubmed: 23555812
Virus Res. 2011 May;157(2):151-60
pubmed: 21056604
J Immunol. 2000 May 15;164(10):5019-22
pubmed: 10799855
Eur J Immunol. 2009 Nov;39(11):3207-16
pubmed: 19658097
PLoS Pathog. 2011 Aug;7(8):e1002172
pubmed: 21852946
Sci Transl Med. 2014 Mar 19;6(228):228ra39
pubmed: 24648342
Nat Rev Immunol. 2020 Feb;20(2):113-127
pubmed: 31666730
Rev Med Virol. 2014 Sep;24(5):291-307
pubmed: 24760655
Int J Cancer. 1975 Aug 15;16(2):216-29
pubmed: 50294
J Virol. 2009 Dec;83(23):12345-54
pubmed: 19793804
Proc Natl Acad Sci U S A. 2018 May 8;115(19):4998-5003
pubmed: 29691324
J Virol. 2018 May 14;92(11):
pubmed: 29540598
Eur J Immunol. 2018 Jan;48(1):50-65
pubmed: 28960320
J Exp Med. 2005 Sep 5;202(5):673-85
pubmed: 16147978
Blood. 2013 Apr 4;121(14):2678-88
pubmed: 23325834
Nat Immunol. 2018 May;19(5):453-463
pubmed: 29632329
Eur J Immunol. 2003 Jan;33(1):194-203
pubmed: 12594848
J Clin Invest. 2017 May 1;127(5):1991-2006
pubmed: 28414293
PLoS Pathog. 2008 Aug 08;4(8):e1000123
pubmed: 18688275
J Immunol. 2012 Nov 15;189(10):5082-8
pubmed: 23077239
Cell Rep. 2017 Aug 29;20(9):2251-2261
pubmed: 28854372
Rev Med Virol. 2016 Mar;26(2):75-89
pubmed: 26572645
Nat Immunol. 2019 Aug;20(8):1004-1011
pubmed: 31263280
Blood. 2012 Mar 15;119(11):2665-74
pubmed: 22180440
Blood. 2012 Dec 6;120(24):4751-60
pubmed: 22983442
Clin Infect Dis. 2008 Mar 1;46(5):732-40
pubmed: 18220478
Rev Med Virol. 2019 May;29(3):e2034
pubmed: 30706584
Mol Immunol. 2006 Mar;43(8):1258-66
pubmed: 16098592
Eur J Immunol. 2016 Oct;46(10):2420-2425
pubmed: 27469079
J Infect Dis. 2020 Mar 5;221(Supplement_1):S113-S122
pubmed: 32134478
Immunity. 2014 Feb 20;40(2):225-34
pubmed: 24440149
J Exp Med. 2010 Aug 30;207(9):2033-41
pubmed: 20713594
J Virol. 2004 Sep;78(18):10023-33
pubmed: 15331735
Nat Immunol. 2005 Feb;6(2):181-8
pubmed: 15640804
J Immunol. 2010 Jul 15;185(2):1093-102
pubmed: 20530255
Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):17965-70
pubmed: 25453106
Antimicrob Agents Chemother. 2017 Jan 24;61(2):
pubmed: 27872061
J Immunol. 2014 Feb 15;192(4):1471-9
pubmed: 24442432
Front Immunol. 2020 Apr 22;11:741
pubmed: 32391021
J Virol. 1996 Nov;70(11):7569-79
pubmed: 8892876
Mol Immunol. 1992 Mar;29(3):319-26
pubmed: 1557042
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6904-9
pubmed: 9192664
Immunity. 2015 Mar 17;42(3):443-56
pubmed: 25786176
J Immunol. 2007 Apr 1;178(7):4473-81
pubmed: 17372005
Sci Transl Med. 2016 Sep 21;8(357):357ra123
pubmed: 27655849
Sci Immunol. 2019 May 10;4(35):
pubmed: 31076527
J Virol. 2019 Nov 13;93(23):
pubmed: 31511385
Immunol Lett. 2007 Sep 15;112(1):58-60
pubmed: 17714794
N Engl J Med. 1982 Jul 1;307(1):7-13
pubmed: 6281647
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14725-32
pubmed: 21825173
Lancet. 1984 Mar 10;1(8376):528-30
pubmed: 6142252
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11327-33
pubmed: 8876135
Nature. 2009 Jan 29;457(7229):557-61
pubmed: 19136945
Sci Rep. 2017 Aug 17;7(1):8661
pubmed: 28819195
PLoS Pathog. 2014 Feb 27;10(2):e1003963
pubmed: 24586166
Lancet. 2011 Apr 9;377(9773):1256-63
pubmed: 21481708
J Infect Dis. 2016 Dec 15;214(12):1916-1923
pubmed: 27923951
Science. 2002 May 17;296(5571):1323-6
pubmed: 11950999
Clin Microbiol Rev. 2013 Jan;26(1):86-102
pubmed: 23297260
J Exp Med. 2014 Dec 15;211(13):2669-80
pubmed: 25422494
J Infect Dis. 1989 May;159(5):860-5
pubmed: 2540247
Blood. 2006 May 1;107(9):3624-31
pubmed: 16384928
PLoS One. 2014 Feb 24;9(2):e89735
pubmed: 24586996
Br J Cancer. 2003 Sep 15;89(6):1130-9
pubmed: 12966437
Trends Immunol. 2015 May;36(5):293-9
pubmed: 25846402
Science. 2007 Jul 20;317(5836):376-81
pubmed: 17641203
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3728-3733
pubmed: 30733288
Elife. 2017 Feb 10;6:
pubmed: 28186488
Immunology. 2020 Jun;160(2):106-115
pubmed: 31630394
Eur J Immunol. 2017 Jun;47(6):1040-1050
pubmed: 28383105
Cell Rep. 2019 Feb 26;26(9):2307-2315.e5
pubmed: 30811982
PLoS Pathog. 2014 May 01;10(5):e1004058
pubmed: 24787765
Annu Rev Immunol. 2013;31:227-58
pubmed: 23516982
Trends Immunol. 2017 May;38(5):307-309
pubmed: 28318877
J Virol. 2016 Jan 06;90(6):3123-37
pubmed: 26739048

Auteurs

Calum Forrest (C)

Institute of Immunity & Transplantation, UCL, Royal Free Campus, London NW3 2PF, UK.

Ariane Gomes (A)

Institute of Immunity & Transplantation, UCL, Royal Free Campus, London NW3 2PF, UK.

Matthew Reeves (M)

Institute of Immunity & Transplantation, UCL, Royal Free Campus, London NW3 2PF, UK.

Victoria Male (V)

Department of Metabolism, Digestion and Reproduction, Imperial College London, Chelsea and Westminster Campus, London SW10 9NH, UK.

Classifications MeSH